APA

Wieland I., Wermes C., Eifrig B., Holstein K., Pollmann H., Siegmund B., Eberl W., Kemkes-Matthes B., Bidlingmaier C., Kurnik K., Lischetzki G., Nimtz-Talaska A., Eisert R., Bogdanova N., Doerk T. & Sykora K. (20120330). Inhibitor-immunology-study. Evaluation of inhibitor development in haemophilia B. : Hamostaseologie.

Chicago

Wieland I, Wermes C, Eifrig B, Holstein K, Pollmann H, Siegmund B, Eberl W, Kemkes-Matthes B, Bidlingmaier C, Kurnik K, Lischetzki G, Nimtz-Talaska A, Eisert R, Bogdanova N, Doerk T and Sykora K-W. 20120330. Inhibitor-immunology-study. Evaluation of inhibitor development in haemophilia B. : Hamostaseologie.

Harvard

Wieland I., Wermes C., Eifrig B., Holstein K., Pollmann H., Siegmund B., Eberl W., Kemkes-Matthes B., Bidlingmaier C., Kurnik K., Lischetzki G., Nimtz-Talaska A., Eisert R., Bogdanova N., Doerk T. and Sykora K. (20120330). Inhibitor-immunology-study. Evaluation of inhibitor development in haemophilia B. : Hamostaseologie.

MLA

Wieland I, Wermes C, Eifrig B, Holstein K, Pollmann H, Siegmund B, Eberl W, Kemkes-Matthes B, Bidlingmaier C, Kurnik K, Lischetzki G, Nimtz-Talaska A, Eisert R, Bogdanova N, Doerk T and Sykora K-W. Inhibitor-immunology-study. Evaluation of inhibitor development in haemophilia B. : Hamostaseologie. 20120330.